1. Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised study. Issue 4 (April 2015) Authors: Cheah, Chan Yoon; Belada, David; Fanale, Michelle A; Janikova, Andrea; Czucman, Myron S; Flinn, Ian W; Kapp, Amy V; Ashkenazi, Avi; Kelley, Sean; Bray, Gordon L; Holden, Scott; Seymour, John F Journal: Lancet Issue: Volume 2:Issue 4(2015) Page Start: e166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗